Publication | Closed Access

Phase II Randomized Trial of Weekly Paclitaxel with or Without Estramustine Phosphate in Progressive, Metastatic, Hormone-Refractory Prostate Cancer

UrologyOncologyMedicineEstramustine PhosphateWeekly PaclitaxelPharmacotherapyCancer TreatmentProstatic DiseasePharmacologyHormone-refractory Prostate Cancer